Overall, ourresults highlight the promise of combining advancedmolecular design with engineered synthesis routes and optical biosensingtechnology to improve detection of melanoma biomarker S100B, potentiallyreduce diagnostic delays and the reliance on biopsy, and ultimatelyenhance clinical decision-making in oncology. Here, S100B is linked to melanoma.